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excluded, and the majority of caval filters are still performed in
the angiography suite or operating room. However, since begin-
ning this program, we have found that the clinicians at our insti-
tution enjoy having this option available for selected patients at
risk for transportation complications.
We agree that comprehensive cost analysis is useful to assess
comparable techniques. The charge analysis showed no significant
difference, and a subsequent cost analysis of a second cohort demon-
strates that the bedside IVUS technique is less expensive. Neither of
these analyses account for lost opportunity for income in the operat-
ing room or angiography suite, which is likely to be significant.
The research protocol was designed with patient safety as a
primary concern, and aseptic techniques approved by the infec-
tion control director of our hospital were used. The thyroid drape
provides length to cover the foot of the bed and side rails, mini-
mizing the risk of contamination. No infections were experienced
in this series. Staff are familiar with aseptic techniques in the
intensive care unit because right heart catheterization, tra-
cheostomy, gastrostomy, abdominal packing changes, and other
more invasive operations are commonly performed when the rel-
ative risks of transportation outweigh bedside risks. Also, the
mobile cart includes backup inventory, and no procedure was
aborted because of catheter malfunction, contamination, or
unavailable supplies. It is important to emphasize planning before
undertaking these procedures.
Intravascular ultrasound scanning may detect some vena cava
abnormalities better than conventional imaging.1 If the anatomy
cannot be clearly defined with IVUS, we would opt for conven-
tional filter placement using fluoroscopy.
We are familiar with the innovative work of Hicks et al with
routine selective renal venography. However, this is not a stand-
ard practice in the placement of caval filters at our institution
because we are not aware of any demonstration of clinical efficacy
with these different techniques. Lastly, postprocedure radi-
ographs were performed in this study to assess positioning, and if
there is a patient with a maldeployed filter, we would recommend
corrective action under fluoroscopic guidance.
In summary, bedside vena cava filter placement is a useful
option for selected patients, although careful planning and famil-
iarity with the technique are important.
James L. Ebaugh, MD
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Regarding “High endogenous estradiol is associated
with increased venous distensibility and clinical
evidence of varicose veins in menopausal women”
We read the article of Ciardullo et al (J Vasc Surg
2001;32:544-9) with great interest, and even more so the com-
ments by Georgiev.1 We agree with Georgiev in that just by meas-
uring estrogen levels, venous capacity, and the rate of varicose
veins, one cannot reach conclusions that “high serum levels of
estrogen induced increased venous distensibility” and that the
connection of this relationship to the incidence of varicose veins
cannot be firmly established based on Ciardullo’s findings. Since
Gregoriev’s letter, it has been shown with appropriate method
that female sex hormones increase venous distensibility.2-3 Since
the above studies also report that venous distensibility decreases
in animal models of menopause, and Ciardullo did not use a con-
trol group with normal cycle, we feel that any speculations for a
direct relationship between increased distensibility and an increase
in venous varicosity should be considered very cautiously.
Moreover, it can further confuse the interpretation of their results
on varicose veins and estrogen level in postmenopausal women
that they did not report the duration of varicose veins. It would
obviously make a big difference whether the menopausal patients
developed varicose veins 1 to 2 years before the study or 20 to 
30 years ago, as many women have varicose veins as early as their
first pregnancy.
Thomas Szaky, MD
Seven Regions Health Centre
Gladstone, Manitoba, Canada
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The title of our paper defines very sharply our point of
view—we affirm that high endogenous estradiol is associated with
increased venous distensibility and clinical evidence of varicose
veins in menopausal women. To evaluate this association, we ana-
lyzed the cross-sectional data of the screenees for a trial on diet
and hormones.1 By indication our design is not conclusive to
demonstrate a causal relationship. We have compared groups of
menopausal women with different venous distensibility and
prevalence of varicose veins and have evaluated their endogenous
statements on causality; according to our findings, it is likely that
the residual estradiol level in menopausal women may play a role,
a starting point for new and specifically structured studies in
women.
We acknowledge the importance of the articles cited by Dr
Szaky. These studies have been carried out in ovariectomized rats
(not in women) and deal with hormone replacement and not with
endogenous hormones; in general, they point out results that we
should expect on the basis of our knowledge on the effect of
estrogen replacement on the venous system.
Dr Szaky’s observation that the absence of a comparison
group of women with normal cycle is the reason to be cautious
has no ground since there he presumes a comparison between
menopausal and premenopausal women, which certainly can
complicate rather than indicate the path to a causal relationship
evaluation.
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Finally, we agree with Dr Szaky that the duration of the vari-
cose veins is an important variable to analyze. It can be notewor-
thy to report that in an Italian survey, a high percentage of
women (38.2%) reported menopause as the starting point of vari-
cose veins.2
Anna V. Ciardullo, MD, MSc
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AUSL Modena, Italy
Salvatore Panico, MD, MSc
Arcangelo Iannuzzi, MD
Paolo Rubba, MD
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Regarding “Early results of infragenicular
revascularization based solely on duplex
arteriography”
In the article entitled “Early results of infragenicular revascu-
larization based solely on duplex arteriography” by Proia et al
(J Vasc Surg 2001;33:1165-70), the authors argued that the dis-
advantages of contrast arteriography include a 2% complication
rate, high cost, and great time consumption.
In support of the first assertion, a single 6-year old study was
cited. My review of the literature was surprising in that only one
recent study was found, documenting insignificant complication
rates from angiography. In a report by Gates and Hartnell,1 over
130 femoral angiograms without a complication were docu-
mented. At the North Shore—Long Island Jewish Health System,
669 contrast angiograms have been performed since January 2001
without a significant complication. My own survey of several other
busy centers indicated that the complication rate of diagnostic
conventional angiograms is 0.5% or less. These results need to be
published because references citing higher rates are outdated.
The argument that arteriograms are more costly than duplex
scans is valid. Current Medicare reimbursement for the physician
and hospital components of a single-leg angiogram is approxi-
mately $1400; for duplex scans it is approximately $275.
The average diagnostic conventional arteriogram takes 30 to
40 minutes to complete. Duplex arteriography in this study
required about an hour. The argument that contrast arteriogra-
phy is time-consuming, therefore, also fails.
A meaningful prospective trial will be difficult to perform
because of the selection bias that the authors mentioned.
Finally, patients with renal failure or severe allergies might be
the primary beneficiaries of this tool, yet they were not men-
tioned in the paper.
Until more compelling reasons to replace contrast angiograms
can be offered, the thought of relying on duplex angiograms for
lower-extremity revascularization will remain as appealing to me as
performing the surgery with mittens.
Steven G. Friedman, MD
North Shore University Hospital
Division of Vascular Surgery
Manhasset, NY
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It was with interest that we read Dr Friedman’s comments.
We appreciate the report of his sample of the complication rates
associated with diagnostic arteriography. Unfortunately, we can
only cite results published in peer-reviewed literature. We also are
convinced that, in centers of excellence with selected patients,
arteriography is a relatively low risk procedure, but even Dr
Friedman would acknowledge that it is not a “no risk” procedure
as duplex ultrasound is. We would remind Dr Friedman in this
context that complications occur 100% to patients who suffer
them, even if the percentage of patients involved is small.
We appreciate Dr Friedman’s report of the reimbursement
difference between arteriography and duplex ultrasound. Given
the demonstrated accuracy of duplex ultrasound, we think it
appropriate to question whether the information obtained by
arteriography is worth the additional $1125 to anyone except the
person receiving the payment.
Dr Friedman’s point regarding the time required for arteri-
ography appears to count only physician time. In our hospital,
patients who undergo arteriograms are required to appear well
before the scheduled time of the study. Technicians are required
to prepare each patient and each room before the study, and
patients remain in the radiology recovery suite recumbent under
observation for at least 4 hours where they are monitored by
nursing personnel. Arteriography may be brief and convenient for
physicians, but it is a long, time-consuming, often painful process
for all others involved. We believe that the time spent by people
other than physicians is important enough to be considered when
selecting a diagnostic test.
Because we believe the above points, as well as other points
made in the article, demonstrate the advantages of duplex ultra-
sound arteriography for all patients, we felt it obvious and redun-
dant to discuss in any detail the advantages of duplex in patients
at great risk of severe complications from arteriography.
Finally, those of us who live in New Hampshire have experi-
ence living in a cold climate. We agree that mittens are an older,
simpler, less elegant way of keeping one’s hands warm. (Despite
Dr Friedman’s implication, we have never considered operating
with them.) We believe that the newer, more efficient, and more
elegant technology represented by gloves (and duplex ultra-
sound) is a better way to achieve our goal.
Daniel B. Walsh, MD
Professor of Surgery
Vice-Chair, Department of Surgery
Section of Vascular Surgery
Dartmouth-Hitchcock Medical Center
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